APA (7th ed.) Citation

Boffa, M. B., Marar, T. T., Yeang, C., Viney, N. J., Xia, S., Witztum, J. L., . . . Tsimikas, S. (2019). Potent reduction of plasma lipoprotein (a) with an antisense oligonucleotide in human subjects does not affect ex vivo fibrinolysis. Journal of lipid research, 60(12), 2082-2089. https://doi.org/10.1194/jlr.P094763

Chicago Style (17th ed.) Citation

Boffa, Michael B., Tanya T. Marar, Calvin Yeang, Nicholas J. Viney, Shuting Xia, Joseph L. Witztum, Marlys L. Koschinsky, and Sotirios Tsimikas. "Potent Reduction of Plasma Lipoprotein (a) with an Antisense Oligonucleotide in Human Subjects Does Not Affect Ex Vivo Fibrinolysis." Journal of Lipid Research 60, no. 12 (2019): 2082-2089. https://doi.org/10.1194/jlr.P094763.

MLA (9th ed.) Citation

Boffa, Michael B., et al. "Potent Reduction of Plasma Lipoprotein (a) with an Antisense Oligonucleotide in Human Subjects Does Not Affect Ex Vivo Fibrinolysis." Journal of Lipid Research, vol. 60, no. 12, 2019, pp. 2082-2089, https://doi.org/10.1194/jlr.P094763.